Synvolux Therapeutics BV

Where the EU money came from

Funding by EU programme. Amounts are Synvolux Therapeutics BV's own share of each project, not the project's full budget.

Projects

2 EU-funded projects, newest first. Each links to the official record.

• GetRadiAssociated partner

  Gene Therapy of Rare Diseases

  Horizon Europe · 2022–2026 · Project on CORDIS ↗
• EpiPredictPartner

  Epigenetic regulation of endocrine therapy resistance in breast cancer: A systems medicine approach to predict treatment outcome

  Horizon 2020 · 2015–2018 · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Kobenhavns UniversitetDenmark · 1 shared project
• Eidgenoessische Technische Hochschule ZuerichSwitzerland · 1 shared project
• Imperial College of Science Technology and MedicineUnited Kingdom · 1 shared project
• The University of EdinburghUnited Kingdom · 1 shared project
• Helsingin YliopistoFinland · 1 shared project
• Universiteit van AmsterdamNetherlands · 1 shared project
• Charite - Universitaetsmedizin BerlinGermany · 1 shared project
• Academisch Ziekenhuis LeidenNetherlands · 1 shared project
• Albert-Ludwigs-Universitaet FreiburgGermany · 1 shared project
• Academisch Ziekenhuis GroningenNetherlands · 1 shared project
• Universita Degli Studi di Napoli Federico IiItaly · 1 shared project
• Deutsches Krebsforschungszentrum HeidelbergGermany · 1 shared project
• Univerzita KarlovaCzech Republic · 1 shared project
• Universita' Degli Studi di Milano-BicoccaItaly · 1 shared project
• Universitaetsklinikum FreiburgGermany · 1 shared project
• Max Delbrueck Centrum Fuer Molekulare Medizin In der Helmholtz-Gemeinschaft (Mdc)Germany · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• DNA
• breast cancer
• drug resistance
• epigenetics
• gene therapy
• metabolomes
• mutation